Rate My Professor Robert Baxter

RB

Robert Baxter

University of Sydney

4.40/5 · 5 reviews
5 Star2
4 Star3
3 Star0
2 Star0
1 Star0
4.08/20/2025

Helps students build confidence and skills.

4.05/21/2025

A role model for academic excellence.

5.03/31/2025

Inspires students to love their studies.

4.02/27/2025

Always approachable and easy to talk to.

5.02/4/2025

Great Professor!

About Robert

Professor Robert C. Baxter is Professor Emeritus in the Sydney Medical School at the University of Sydney, having served as Professor since 1992 and attaining emeritus status in 2019. He directed the Kolling Institute of Medical Research at Royal North Shore Hospital from 1994 to 2011, where he advanced research in endocrinology and cell biology. Baxter completed his BSc in 1968, PhD in 1973, and DSc in 1990, all at the University of Sydney. His academic career has been marked by leadership in medical research, including roles as past President of the Endocrine Society of Australia, member of the NHMRC Research Committee, and chair of the Cancer Australia Research Committee. He is also a Life Member of the Endocrine Society of Australia since 2004 and a Medical Foundation Fellow.

A distinguished cancer researcher, Baxter possesses primary expertise in biochemistry, cell biology, and proteomics, underpinned by a background in endocrinology and metabolic research. His seminal contributions focus on insulin-like growth factor binding proteins (IGFBPs) and their signaling pathways, particularly in relation to tumor growth and breast cancer progression. With over 300 peer-reviewed publications, his work has garnered more than 35,000 citations and an h-index of 96 on Google Scholar. Key publications include 'Insulin-like growth factor-binding protein from human plasma. Purification and characterization' (Journal of Biological Chemistry, 1986), 'Cellular actions of the insulin-like growth factor binding proteins' (Endocrine Reviews, 2002), 'Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities' (American Journal of Physiology-Endocrinology and Metabolism, 2000), and 'Signaling Pathways of the Insulin-like Growth Factor Binding Proteins' (Endocrine Reviews, 2023). Baxter's research has significantly influenced understandings of IGFBP functions in cancer and metabolic diseases, contributing to advancements in targeted therapies. In recognition of his impact, he was awarded the Member (AM) of the Order of Australia in 2020 for significant service to medical research. He has secured funding such as the Cancer Institute NSW grant for 'ZOOMing in on new cancer therapies: Real-time quantitative live cell imaging for cancer research and drug discovery' in 2017.

Professional Email: robert.baxter@sydney.edu.au